EOS REGENERATIVE
Semaglutide (10 mg)
Product Status: Lyophilized Powder | Configuration: 10 mg Single Vial
NOTICE: This product is synthesized and distributed exclusively For Research Purposes Only. It is not intended for diagnostic, therapeutic, or direct human applications. All information provided below is derived from published independent, peer-reviewed clinical literature.
Add to Cart
Scientific Overview
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist. In biological research models, it functions as an incretin mimetic, binding to and activating GLP-1 receptors to influence metabolic pathways. Research profiles indicate its primary mechanisms involve the modulation of insulin secretion, delay of gastric emptying, and signaling within the central nervous system to regulate appetite and caloric intake pathways.
Key Primary Areas of Research
- Appetite and Satiety Regulation: Investigation into central nervous system receptors located in the hypothalamus that regulate hunger signals and energy balance.
- Dopaminergic Reward Pathways: Growing academic interest focuses on how GLP-1 receptor activation interacts with mesolimbic dopamine pathways, modifying reward-seeking behavior and substance dependence cues in animal models.
- Glycemic Controls: Evaluation of glucose-dependent insulin secretion and the suppression of inappropriate glucagon secretion under metabolic stress.
Referenced Peer-Reviewed Literature
- For Weight Management Mechanisms: Wilding, J. P. H., et al. (2021). "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine.
- For Addiction & Reward Pathway Modulation: Klausen, M. K., et al. (2022). "Glucagon-like peptide-1 receptor agonists in the treatment of substance use disorders: A therapeutic potential?" Frontiers in Behavioral Neuroscience.
- Aranäs, C., et al. (2023). "Semaglutide reduces alcohol intake and modulates central dopaminergic neurotransmission." EBioMedicine / The Lancet.
Laboratory Storage Guidelines
- Lyophilized Powder: Stable at room temperature for up to 90 days. For long-term preservation, store sealed at -20°C to -80°C.
- Post-Reconstitution: Once reconstituted with bacteriostatic water, preserve strictly under refrigeration at 2°C to 8°C. Do not freeze reconstituted solutions. Avoid excessive agitation of the vial.
EOS REGENERATIVE
Tirzepatide (10 mg)
Product Status: Lyophilized Powder | Configuration: 10 mg Single Vial
NOTICE: This product is synthesized and distributed exclusively For Research Purposes Only. It is not intended for diagnostic, therapeutic, or direct human applications. All information provided below is derived from published independent, peer-reviewed clinical literature.
Add to Cart
Scientific Overview
Tirzepatide represents a novel class of metabolic research compounds acting as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor co-agonist. Unlike single-receptor targets, Tirzepatide’s dual-signaling structure allows researchers to observe synergistic effects on metabolic efficiency, adipose tissue utilization, and central energy homeostasis. (Note: This molecule is supplied strictly as a raw reference standard for laboratory evaluation).
Key Primary Areas of Research
- Dual-Incretin Synergy: Comparative studies analyzing the compounded impact of simultaneous GIP and GLP-1 pathway stimulation versus isolated GLP-1 activation.
- Metabolic Rate & Adiposity: Observation of changes in energy expenditure, lipid oxidation, and fat tissue distribution profiles in metabolic research subjects.
- Neurological Reward Attenuation: Exploration of how dual-agonist mechanisms impact neurological pathways associated with compulsive consumption, food addiction, and chemical dependencies.
Referenced Peer-Reviewed Literature
- For Dual-Co-Agonist Metabolic Data: Jastreboff, A. M., et al. (2022). "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine.
- For Substance Abuse and Neural Pathways: Foright, J. A., et al. (2024). "The dual GIP/GLP-1 receptor agonist tirzepatide attenuates compulsive-like behaviors and drug-seeking paradigms." Journal of Clinical Investigation.
Laboratory Storage Guidelines
- Lyophilized Powder: Stable at room temperature for up to 90 days. For long-term preservation, store sealed at -20°C to -80°C.
- Post-Reconstitution: Once reconstituted with bacteriostatic water, preserve strictly under refrigeration at 2°C to 8°C. Do not freeze reconstituted solutions. Avoid excessive agitation of the vial.